Recall check › FDA press release
Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride Injection CarpujectTM Units and Labetalol Hydrochloride Injection, USP CarpujectTM Units Due to the Potential for Incomplete Crimp Seals
Recall announced May 22, 2024 Ended · shown as history
The problem
Device & Drug Safety - Potential Packaging Defect
Which products
Hospira Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units
Is yours affected?
Only the units with the lot codes or dates below are affected. Compare them with the code printed on your package.
- Lot codes
- HJ3965
- 03
- HJ7566
- 20MG4
- Best-by / expiration
- Sep 30, 2024, May 31, 2025
- Package sizes
- 4 ml
Code information as published: Lot HJ3965; Best by 2024/09 ; Lot 0.3 mg base/mL; Best by 10 cartridge units/carton ; Lot HJ7566; Best by 2025/05 ; Lot 20 mg/4 mL (5 mg/mL); Best by 10 carton/ cartridge units/bundle
Details
- Firm: Hospira Inc.
- Type: Animal drug
- Why it's shown as history: the last listed date passed (Invalid Date).
Source: U.S. Food and Drug Administration, recalls press releases. Lot codes, dates and UPCs are extracted automatically from FDA's text; always check the official notice.